Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-25-065210
Filing Date
2025-03-27
Accepted
2025-03-27 13:39:15
Documents
19
Effectiveness Date
2025-03-27

Document Format Files

Seq Description Document Type Size
1 S-8 d941880ds8.htm S-8 50785
2 EX-4.5 d941880dex45.htm EX-4.5 15008
3 EX-5.1 d941880dex51.htm EX-5.1 5421
4 EX-23.1 d941880dex231.htm EX-23.1 2149
5 EX-23.2 d941880dex232.htm EX-23.2 1604
6 EX-23.3 d941880dex233.htm EX-23.3 1935
7 EX-FILING FEES d941880dexfilingfees.htm   iXBRL EX-FILING FEES 44924
  Complete submission text file 0001193125-25-065210.txt   307564

Data Files

Seq Description Document Type Size
21 EXTRACTED XBRL INSTANCE DOCUMENT d941880dexfilingfees_htm.xml XML 16077
Mailing Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017
Business Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017 33153774400
Sanofi (Filer) CIK: 0001121404 (see all company filings)

EIN.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-286161 | Film No.: 25778457
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)